Literature
Hide
Curated publication monitor with source mix, recency, and trace links into studies and reports. Business and scientific purpose: this view supports faster, evidence-based drug discovery decisions across research, operations, and governance teams. Literature is connected to linked entities, metrics, and workflow actions in this workspace. Use these panels to review evidence, identify risks, and decide the next best scientific action. The view uses deterministic demo data shaped to mirror realistic drug discovery operations.
Recent Reading Queue
LIT-0001Pathway activation 1 • NatureLIT-0002Mechanism study 2 • ScienceLIT-0003Combination therapy 3 • PubMedLIT-0004Pathway activation 4 • PubMedLIT-0005Pathway activation 5 • bioRxivLIT-0006Mechanism study 6 • bioRxivLIT-0007Pathway activation 7 • PubMedLIT-0008Target validation 8 • PubMedLIT-0009Combination therapy 9 • PubMedLIT-0010Pathway activation 10 • bioRxiv
Publication Index
| id | title | source | date |
|---|---|---|---|
| LIT-0001 | Pathway activation 1 | Nature | 2025-03-12T00:00:00.000Z |
| LIT-0002 | Mechanism study 2 | Science | 2025-07-09T00:00:00.000Z |
| LIT-0003 | Combination therapy 3 | PubMed | 2025-10-01T00:00:00.000Z |
| LIT-0004 | Pathway activation 4 | PubMed | 2025-04-20T00:00:00.000Z |
| LIT-0005 | Pathway activation 5 | bioRxiv | 2025-04-02T00:00:00.000Z |
| LIT-0006 | Mechanism study 6 | bioRxiv | 2025-01-22T00:00:00.000Z |
| LIT-0007 | Pathway activation 7 | PubMed | 2025-03-10T00:00:00.000Z |
| LIT-0008 | Target validation 8 | PubMed | 2025-11-10T00:00:00.000Z |
| LIT-0009 | Combination therapy 9 | PubMed | 2025-06-10T00:00:00.000Z |
| LIT-0010 | Pathway activation 10 | bioRxiv | 2025-06-14T00:00:00.000Z |
| LIT-0011 | Mechanism study 11 | bioRxiv | 2025-11-23T00:00:00.000Z |
| LIT-0012 | Combination therapy 12 | PubMed | 2025-04-27T00:00:00.000Z |
| LIT-0013 | Mechanism study 13 | bioRxiv | 2025-04-08T00:00:00.000Z |
| LIT-0014 | Combination therapy 14 | Nature | 2025-11-20T00:00:00.000Z |
| LIT-0015 | Combination therapy 15 | bioRxiv | 2025-01-15T00:00:00.000Z |
| LIT-0016 | Mechanism study 16 | Science | 2025-12-02T00:00:00.000Z |
| LIT-0017 | Combination therapy 17 | Science | 2025-05-19T00:00:00.000Z |
| LIT-0018 | Mechanism study 18 | Nature | 2025-06-03T00:00:00.000Z |
| LIT-0019 | Mechanism study 19 | bioRxiv | 2025-02-15T00:00:00.000Z |
| LIT-0020 | Target validation 20 | Science | 2025-04-18T00:00:00.000Z |
| LIT-0021 | Pathway activation 21 | Science | 2025-07-19T00:00:00.000Z |
| LIT-0022 | Target validation 22 | Nature | 2025-11-01T00:00:00.000Z |
| LIT-0023 | Pathway activation 23 | bioRxiv | 2025-02-06T00:00:00.000Z |
| LIT-0024 | Combination therapy 24 | PubMed | 2025-09-01T00:00:00.000Z |
| LIT-0025 | Pathway activation 25 | PubMed | 2025-09-01T00:00:00.000Z |
| LIT-0026 | Pathway activation 26 | Nature | 2025-05-27T00:00:00.000Z |
| LIT-0027 | Target validation 27 | Science | 2025-01-02T00:00:00.000Z |
| LIT-0028 | Combination therapy 28 | Nature | 2025-10-22T00:00:00.000Z |
| LIT-0029 | Pathway activation 29 | PubMed | 2025-05-17T00:00:00.000Z |
| LIT-0030 | Mechanism study 30 | Nature | 2025-09-02T00:00:00.000Z |
| LIT-0031 | Pathway activation 31 | Science | 2025-06-08T00:00:00.000Z |
| LIT-0032 | Pathway activation 32 | bioRxiv | 2025-10-05T00:00:00.000Z |
| LIT-0033 | Mechanism study 33 | PubMed | 2025-11-10T00:00:00.000Z |
| LIT-0034 | Target validation 34 | bioRxiv | 2025-02-19T00:00:00.000Z |
| LIT-0035 | Target validation 35 | Science | 2025-09-18T00:00:00.000Z |
| LIT-0036 | Mechanism study 36 | Nature | 2025-09-23T00:00:00.000Z |
| LIT-0037 | Combination therapy 37 | PubMed | 2025-02-27T00:00:00.000Z |
| LIT-0038 | Target validation 38 | bioRxiv | 2025-08-23T00:00:00.000Z |
| LIT-0039 | Mechanism study 39 | Nature | 2025-05-19T00:00:00.000Z |
| LIT-0040 | Target validation 40 | bioRxiv | 2025-05-24T00:00:00.000Z |
| LIT-0041 | Pathway activation 41 | PubMed | 2025-03-12T00:00:00.000Z |
| LIT-0042 | Mechanism study 42 | Science | 2025-07-06T00:00:00.000Z |
| LIT-0043 | Mechanism study 43 | Science | 2025-12-01T00:00:00.000Z |
| LIT-0044 | Mechanism study 44 | Science | 2025-12-17T00:00:00.000Z |
| LIT-0045 | Combination therapy 45 | Nature | 2025-05-19T00:00:00.000Z |
| LIT-0046 | Combination therapy 46 | Nature | 2025-08-09T00:00:00.000Z |
| LIT-0047 | Mechanism study 47 | bioRxiv | 2025-12-08T00:00:00.000Z |
| LIT-0048 | Combination therapy 48 | Science | 2025-06-12T00:00:00.000Z |
| LIT-0049 | Combination therapy 49 | bioRxiv | 2025-11-16T00:00:00.000Z |
| LIT-0050 | Target validation 50 | PubMed | 2025-12-23T00:00:00.000Z |
| LIT-0051 | Pathway activation 51 | PubMed | 2025-02-26T00:00:00.000Z |
| LIT-0052 | Mechanism study 52 | Nature | 2025-07-25T00:00:00.000Z |
| LIT-0053 | Pathway activation 53 | bioRxiv | 2025-09-18T00:00:00.000Z |
| LIT-0054 | Pathway activation 54 | Science | 2025-02-20T00:00:00.000Z |
| LIT-0055 | Combination therapy 55 | Science | 2025-08-12T00:00:00.000Z |
| LIT-0056 | Pathway activation 56 | Nature | 2025-04-24T00:00:00.000Z |
| LIT-0057 | Mechanism study 57 | PubMed | 2025-07-27T00:00:00.000Z |
| LIT-0058 | Mechanism study 58 | Nature | 2025-05-23T00:00:00.000Z |
| LIT-0059 | Pathway activation 59 | bioRxiv | 2025-09-08T00:00:00.000Z |
| LIT-0060 | Pathway activation 60 | Nature | 2025-08-14T00:00:00.000Z |
| LIT-0061 | Target validation 61 | Nature | 2025-07-10T00:00:00.000Z |
| LIT-0062 | Target validation 62 | bioRxiv | 2025-12-07T00:00:00.000Z |
| LIT-0063 | Mechanism study 63 | Science | 2025-02-17T00:00:00.000Z |
| LIT-0064 | Combination therapy 64 | bioRxiv | 2025-03-07T00:00:00.000Z |
| LIT-0065 | Combination therapy 65 | PubMed | 2025-04-16T00:00:00.000Z |
| LIT-0066 | Combination therapy 66 | bioRxiv | 2025-12-02T00:00:00.000Z |
| LIT-0067 | Pathway activation 67 | Science | 2025-04-03T00:00:00.000Z |
| LIT-0068 | Target validation 68 | bioRxiv | 2025-02-12T00:00:00.000Z |
| LIT-0069 | Combination therapy 69 | Science | 2025-06-27T00:00:00.000Z |
| LIT-0070 | Pathway activation 70 | PubMed | 2025-12-22T00:00:00.000Z |
| LIT-0071 | Target validation 71 | Science | 2025-04-19T00:00:00.000Z |
| LIT-0072 | Combination therapy 72 | PubMed | 2025-03-27T00:00:00.000Z |
| LIT-0073 | Pathway activation 73 | PubMed | 2025-02-17T00:00:00.000Z |
| LIT-0074 | Target validation 74 | Nature | 2025-09-03T00:00:00.000Z |
| LIT-0075 | Target validation 75 | bioRxiv | 2025-08-05T00:00:00.000Z |
| LIT-0076 | Target validation 76 | PubMed | 2025-06-03T00:00:00.000Z |
| LIT-0077 | Combination therapy 77 | bioRxiv | 2025-03-08T00:00:00.000Z |
| LIT-0078 | Target validation 78 | bioRxiv | 2025-08-04T00:00:00.000Z |
| LIT-0079 | Mechanism study 79 | Nature | 2025-01-05T00:00:00.000Z |
| LIT-0080 | Mechanism study 80 | bioRxiv | 2025-06-13T00:00:00.000Z |
| LIT-0081 | Combination therapy 81 | PubMed | 2025-02-22T00:00:00.000Z |
| LIT-0082 | Combination therapy 82 | Science | 2025-08-09T00:00:00.000Z |
| LIT-0083 | Mechanism study 83 | Science | 2025-07-21T00:00:00.000Z |
| LIT-0084 | Mechanism study 84 | Nature | 2025-06-24T00:00:00.000Z |
| LIT-0085 | Target validation 85 | bioRxiv | 2025-03-20T00:00:00.000Z |
| LIT-0086 | Target validation 86 | Nature | 2025-10-04T00:00:00.000Z |
| LIT-0087 | Target validation 87 | Science | 2025-02-26T00:00:00.000Z |
| LIT-0088 | Target validation 88 | Science | 2025-02-10T00:00:00.000Z |
| LIT-0089 | Combination therapy 89 | PubMed | 2025-06-21T00:00:00.000Z |
| LIT-0090 | Mechanism study 90 | Science | 2025-06-19T00:00:00.000Z |
| LIT-0091 | Mechanism study 91 | Nature | 2025-07-25T00:00:00.000Z |
| LIT-0092 | Pathway activation 92 | Nature | 2025-10-06T00:00:00.000Z |
| LIT-0093 | Mechanism study 93 | Nature | 2025-07-16T00:00:00.000Z |
| LIT-0094 | Combination therapy 94 | Nature | 2025-02-18T00:00:00.000Z |
| LIT-0095 | Mechanism study 95 | Nature | 2025-08-27T00:00:00.000Z |
| LIT-0096 | Pathway activation 96 | Science | 2025-08-26T00:00:00.000Z |
| LIT-0097 | Target validation 97 | Science | 2025-05-28T00:00:00.000Z |
| LIT-0098 | Mechanism study 98 | PubMed | 2025-01-18T00:00:00.000Z |
| LIT-0099 | Mechanism study 99 | Science | 2025-07-09T00:00:00.000Z |
| LIT-0100 | Pathway activation 100 | Science | 2025-11-09T00:00:00.000Z |
| LIT-0101 | Pathway activation 101 | Science | 2025-08-09T00:00:00.000Z |
| LIT-0102 | Target validation 102 | bioRxiv | 2025-12-14T00:00:00.000Z |
| LIT-0103 | Combination therapy 103 | PubMed | 2025-03-03T00:00:00.000Z |
| LIT-0104 | Combination therapy 104 | Nature | 2025-09-26T00:00:00.000Z |
| LIT-0105 | Mechanism study 105 | Nature | 2025-05-06T00:00:00.000Z |
| LIT-0106 | Combination therapy 106 | PubMed | 2025-10-02T00:00:00.000Z |
| LIT-0107 | Mechanism study 107 | PubMed | 2025-06-20T00:00:00.000Z |
| LIT-0108 | Target validation 108 | PubMed | 2025-10-27T00:00:00.000Z |
| LIT-0109 | Combination therapy 109 | PubMed | 2025-09-24T00:00:00.000Z |
| LIT-0110 | Pathway activation 110 | Science | 2025-07-19T00:00:00.000Z |
| LIT-0111 | Combination therapy 111 | Nature | 2025-03-27T00:00:00.000Z |
| LIT-0112 | Target validation 112 | Science | 2025-11-14T00:00:00.000Z |
| LIT-0113 | Mechanism study 113 | PubMed | 2025-04-13T00:00:00.000Z |
| LIT-0114 | Target validation 114 | bioRxiv | 2025-09-19T00:00:00.000Z |
| LIT-0115 | Target validation 115 | PubMed | 2025-12-11T00:00:00.000Z |
| LIT-0116 | Combination therapy 116 | PubMed | 2025-08-01T00:00:00.000Z |
| LIT-0117 | Target validation 117 | bioRxiv | 2025-10-27T00:00:00.000Z |
| LIT-0118 | Target validation 118 | Nature | 2025-06-25T00:00:00.000Z |
| LIT-0119 | Target validation 119 | bioRxiv | 2025-06-20T00:00:00.000Z |
| LIT-0120 | Combination therapy 120 | Nature | 2025-05-08T00:00:00.000Z |
| LIT-0121 | Target validation 121 | Science | 2025-03-10T00:00:00.000Z |
| LIT-0122 | Mechanism study 122 | Science | 2025-06-08T00:00:00.000Z |
| LIT-0123 | Mechanism study 123 | Nature | 2025-08-18T00:00:00.000Z |
| LIT-0124 | Mechanism study 124 | Science | 2025-03-18T00:00:00.000Z |
| LIT-0125 | Mechanism study 125 | Science | 2025-02-04T00:00:00.000Z |
| LIT-0126 | Pathway activation 126 | Nature | 2025-01-07T00:00:00.000Z |
| LIT-0127 | Combination therapy 127 | PubMed | 2025-12-20T00:00:00.000Z |
| LIT-0128 | Target validation 128 | PubMed | 2025-12-05T00:00:00.000Z |
| LIT-0129 | Mechanism study 129 | Nature | 2025-03-02T00:00:00.000Z |
| LIT-0130 | Target validation 130 | Science | 2025-11-14T00:00:00.000Z |
| LIT-0131 | Pathway activation 131 | bioRxiv | 2025-05-19T00:00:00.000Z |
| LIT-0132 | Target validation 132 | PubMed | 2025-05-24T00:00:00.000Z |
| LIT-0133 | Mechanism study 133 | PubMed | 2025-05-06T00:00:00.000Z |
| LIT-0134 | Pathway activation 134 | PubMed | 2025-10-06T00:00:00.000Z |
| LIT-0135 | Pathway activation 135 | PubMed | 2025-04-28T00:00:00.000Z |
| LIT-0136 | Combination therapy 136 | Nature | 2025-09-02T00:00:00.000Z |
| LIT-0137 | Combination therapy 137 | Nature | 2025-12-22T00:00:00.000Z |
| LIT-0138 | Combination therapy 138 | PubMed | 2025-01-04T00:00:00.000Z |
| LIT-0139 | Mechanism study 139 | PubMed | 2025-04-23T00:00:00.000Z |
| LIT-0140 | Pathway activation 140 | Nature | 2025-02-12T00:00:00.000Z |
| LIT-0141 | Mechanism study 141 | PubMed | 2025-12-19T00:00:00.000Z |
| LIT-0142 | Combination therapy 142 | Science | 2025-04-16T00:00:00.000Z |
| LIT-0143 | Combination therapy 143 | PubMed | 2025-04-07T00:00:00.000Z |
| LIT-0144 | Target validation 144 | Science | 2025-01-20T00:00:00.000Z |
| LIT-0145 | Mechanism study 145 | PubMed | 2025-11-12T00:00:00.000Z |
| LIT-0146 | Target validation 146 | bioRxiv | 2025-01-17T00:00:00.000Z |
| LIT-0147 | Mechanism study 147 | Nature | 2025-05-19T00:00:00.000Z |
| LIT-0148 | Target validation 148 | Nature | 2025-07-14T00:00:00.000Z |
| LIT-0149 | Mechanism study 149 | PubMed | 2025-11-06T00:00:00.000Z |
| LIT-0150 | Mechanism study 150 | PubMed | 2025-08-05T00:00:00.000Z |
| LIT-0151 | Mechanism study 151 | bioRxiv | 2025-04-25T00:00:00.000Z |
| LIT-0152 | Mechanism study 152 | Science | 2025-07-18T00:00:00.000Z |
| LIT-0153 | Target validation 153 | PubMed | 2025-04-27T00:00:00.000Z |
| LIT-0154 | Mechanism study 154 | bioRxiv | 2025-06-11T00:00:00.000Z |
| LIT-0155 | Mechanism study 155 | Science | 2025-11-17T00:00:00.000Z |
| LIT-0156 | Pathway activation 156 | Science | 2025-09-12T00:00:00.000Z |
| LIT-0157 | Mechanism study 157 | bioRxiv | 2025-08-19T00:00:00.000Z |
| LIT-0158 | Pathway activation 158 | bioRxiv | 2025-09-15T00:00:00.000Z |
| LIT-0159 | Pathway activation 159 | Nature | 2025-07-16T00:00:00.000Z |
| LIT-0160 | Mechanism study 160 | bioRxiv | 2025-02-22T00:00:00.000Z |
| LIT-0161 | Mechanism study 161 | PubMed | 2025-08-23T00:00:00.000Z |
| LIT-0162 | Combination therapy 162 | PubMed | 2025-04-13T00:00:00.000Z |
| LIT-0163 | Pathway activation 163 | Science | 2025-03-03T00:00:00.000Z |
| LIT-0164 | Mechanism study 164 | PubMed | 2025-12-06T00:00:00.000Z |
| LIT-0165 | Combination therapy 165 | bioRxiv | 2025-06-11T00:00:00.000Z |
| LIT-0166 | Target validation 166 | Nature | 2025-07-12T00:00:00.000Z |
| LIT-0167 | Target validation 167 | Nature | 2025-09-19T00:00:00.000Z |
| LIT-0168 | Combination therapy 168 | Nature | 2025-03-07T00:00:00.000Z |
| LIT-0169 | Pathway activation 169 | Nature | 2025-01-13T00:00:00.000Z |
| LIT-0170 | Pathway activation 170 | PubMed | 2025-06-05T00:00:00.000Z |
| LIT-0171 | Mechanism study 171 | Science | 2025-05-03T00:00:00.000Z |
| LIT-0172 | Target validation 172 | Science | 2025-02-09T00:00:00.000Z |
| LIT-0173 | Mechanism study 173 | Nature | 2025-06-12T00:00:00.000Z |
| LIT-0174 | Target validation 174 | bioRxiv | 2025-06-11T00:00:00.000Z |
| LIT-0175 | Mechanism study 175 | Nature | 2025-04-21T00:00:00.000Z |
| LIT-0176 | Pathway activation 176 | PubMed | 2025-08-07T00:00:00.000Z |
| LIT-0177 | Target validation 177 | Science | 2025-06-17T00:00:00.000Z |
| LIT-0178 | Mechanism study 178 | Science | 2025-04-18T00:00:00.000Z |
| LIT-0179 | Mechanism study 179 | bioRxiv | 2025-09-11T00:00:00.000Z |
| LIT-0180 | Target validation 180 | Nature | 2025-04-07T00:00:00.000Z |